Patent Assignment
Reel/Frame 013974/0465
Assignment of Assignor's Interest
Recorded: 2003-09-16
Pages: 13
Assignor
BAYER CORPORATION
Executed: 2003-06-03
Assignee
BAYER PHARMACEUTICALS CORPORATION
400 MORGAN LANE, WEST HAVEN, CONNECTICUT, 06518
Covered Properties
(56)
Human Interleukin 6 Inhibitor
Patent:
5,527,546 →
Application:
08/288,516 →
Method of Selecting Mammalian Cell Lines Having Improved Productivity
Patent:
5,612,213 →
Application:
08/333,706 →
Monoclonal Antibody 369.2B Specific for Beta A4 Peptide
Patent:
5,786,180 →
Application:
08/388,463 →
Method of Treating Bacterial Meningitis with Anti-Tumor Necrosis Factor Antibody
Patent:
5,616,321 →
Application:
08/410,006 →
Human Anti-Tnf Antibodies
Patent:
5,654,407 →
Application:
08/435,246 →
Dissemination of Fungal Infections: Animal Model and Method of Prophylaxis
Patent:
5,833,946 →
Application:
08/465,039 →
Method of Isolating Bay Peptide Species Ending at Carboxy-Terminals Residue 42 Using Monoclonal Antibody 369.2B
Patent:
5,693,753 →
Application:
08/472,627 →
Methods of Detecting BA4 Peptide Species Ending at Carboxy-Terminus Residue 42 Using Monoclonal Antibody 369.2B
Patent:
5,679,531 →
Application:
08/484,969 →
Derivatives of Substituted 4-Biarylbutyric Acid as Matrix Metallo- Protease Inhibitors
Patent:
5,789,434 →
Application:
08/539,409 →
Cell Surface Receptor Complementation
Patent:
5,658,746 →
Application:
08/552,432 →
Neuropeptide Y Receptor Y5 and Nucleic Acid Sequences
Patent:
5,919,901 →
Application:
08/630,118 →
Galanin Receptor 2 Protein
Patent:
6,410,686 →
Application:
08/665,034 →
Enhanced Protein Production Method
Patent:
5,854,021 →
Application:
08/807,415 →
Neuropeptide Y Receptor Y5 and Nucleic Acid Sequences
Patent:
5,965,392 →
Application:
08/838,399 →
Inhibition of Matrix Metalloproteases by Substituted Biaryl Oxobutyric Acids
Patent:
5,925,637 →
Application:
08/856,693 →
Biaryl Acetylenes as Inhibitors of Matrix Metalloproteases
Patent:
5,968,795 →
Application:
08/856,694 →
Inhibition of Matrix Metalloproproteases by 2-(Omega-Arolalkyl)-4-Biaryl-4-Oxobutyric Acids
Patent:
5,932,763 →
Application:
08/856,695 →
Inhibition of Matrix Metalloproteases by Substituted Phenalkyl Compounds
Patent:
5,804,581 →
Application:
08/856,696 →
Substituted 4-Arylbutyric Acid Derivatives as Matrix Metalloprotease Inhibitors
Patent:
5,863,915 →
Application:
08/857,004 →
Substituted Oxobutyric Acids as Matrix Metalloprotease Inhibitors
Patent:
5,932,577 →
Application:
08/857,053 →
Substituted Cycloalkanecarboxylic Acid Derivatives as Matrix Metalloprotease Inhibitors
Patent:
5,874,473 →
Application:
08/864,666 →
Thiophone-Containing Butonic Acid Derivatives as Matrix Metalloprotease Inhibitors
Patent:
5,886,024 →
Application:
08/865,325 →
Thiophenebutanoic Acid Derivatives as Matrix Metalloprotease Inhibitors
Patent:
5,854,277 →
Application:
08/865,689 →
Substituted Cycloalkanecarboxylic Acid Derivatives as Matrix Metalliprotease Inhibitors
Patent:
5,886,022 →
Application:
08/866,568 →
Substituted 4-Biarylbutyric Acid Derivatives as Matrix Metalloprotease Inhibitors
Patent:
5,861,427 →
Application:
08/866,679 →
Substituted 4-Biarylbutyric Acid Derivatives as Matrix Metalloprotease Inhibitors
Patent:
5,861,428 →
Application:
08/866,680 →
Substituted 4-Biarylbutyric or Acid Derivatives as Matrix Metalloprotease Inhibitors
Patent:
5,886,043 →
Application:
08/866,778 →
Substituted 4-Biarylbutyric Acid Derivatives as Matrix Meltalloprotease Inhibitors
Patent:
5,859,047 →
Application:
08/866,798 →
T-Cell Selective Interleukin-4 Agonists
Patent:
5,986,059 →
Application:
08/874,697 →
High-Affinity Interleukin-4 Muteins
Patent:
6,028,176 →
Application:
08/897,020 →
Substituted Biphenyls
Patent:
6,218,431 →
Application:
08/904,119 →
Method for Treating Asthma Using Scf Antibody
Patent:
5,911,988 →
Application:
08/912,541 →
Substituted 4-Biphenyl-4-Hydroxybutyric Acid Derivatives as Matrix Metalloprotease Inhibitors
Patent:
5,939,583 →
Application:
08/960,921 →
NPY5 Receptor Antagonists and Methods for Using Same
Patent:
5,939,462 →
Application:
09/023,351 →
Amide Derivatives and Methods for Using the Same as Selective Neuropeptide Y Receptor Antagonists
Patent:
6,048,900 →
Application:
09/023,498 →
Substituted 5-Biarylpentanoic Acids and Derivatives as Matrix Metalloprotease Inhibitors
Patent:
6,166,082 →
Application:
09/057,679 →
Substituted 4-Biarylbutyric and 5-Biarylpentanoic Acid Derivatives as Matrix Metalloprotease Inhibitors
Patent:
6,288,063 →
Application:
09/085,909 →
Compositions for Nasal Drug Delivery, Methods of Making Same, and Methods of Removing Residual Solvent from Pharmaceutical Preparations
Patent:
6,391,452 →
Application:
09/118,463 →
Methods and Constructs for Protein Expression
Patent:
6,051,401 →
Application:
09/124,605 →
Novel Sulfonamide Substituted Chroman Derivatives Useful as Beta 3 Adrenoreceptor Agonists
Patent:
6,051,586 →
Application:
09/199,014 →
Vectors Having Terminal Repeat Sequence of Epstein-Barr Virus
Patent:
6,180,108 →
Application:
09/209,915 →
Human Hybrid Host Cell for Mammalian Gene Expression
Patent:
6,136,599 →
Application:
09/209,920 →
Novel Carboxyl Substituted Chroman Derivatives Useful as Beta 3 Adrenoreceptor Agonists
Patent:
6,469,031 →
Application:
09/216,512 →
Neuropeptide Y Receptor Y5 and Nucleic Acid Sequences
Patent:
6,207,799 →
Application:
09/235,839 →
NPY5 Receptor Antagonists and Methods for Using Same
Patent:
6,245,817 →
Application:
09/295,073 →
T-Cell Selective Interleukin-4 Agonists
Patent:
6,335,426 →
Application:
09/298,374 →
Process and Medium for Mammalian Cell Culture Under Low Dissolved Carbon Dioxide Concentration
Patent:
6,338,964 →
Application:
09/307,175 →
Interleukin-2 Mutein Expressed from Mammalian Cells
Patent:
6,348,192 →
Application:
09/310,026 →
Neuropeptide Y Receptor Y5 and Nucleic Acid Sequences
Patent:
6,368,824 →
Application:
09/327,035 →
Inhibition of Matrix Metalloproteases by Substituted Biaryl Oxobutyric Acids
Patent:
6,225,314 →
Application:
09/343,142 →
Dna Encoding High Affinity Interleukin-4 Muteins
Patent:
6,313,272 →
Application:
09/350,823 →
Protein Having Proteinase Inhibitor Activity
Patent:
6,294,648 →
Application:
09/358,569 →
Protein Having Proteinase Inhibitor Activity
Patent:
6,180,607 →
Application:
09/369,494 →
Polynucleotides Encoding T-Cell Selective Interleukin-4 Agonists
Patent:
6,433,157 →
Application:
09/408,629 →
Substituted 2-Arylimino Heterocycles and Compositions Containing Them, for Use as Progesterone Receptor Binding Agents
Patent:
6,353,006 →
Application:
09/453,613 →
Method for Evaluating Target Protein Quality from Fermenter
Patent:
6,214,975 →
Application:
09/466,711 →
Related Assignments
(23)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 10, 1994
From: PENZA, DELIA E.; FARIS, SUSAN K.; LEMBACH, KENNETH J.
To: MILES INC.
Reel/Frame 007106/0799 →
Assignment of Assignor's Interest
Nov 3, 1994
From: CHAN, SHAM-YUEN
To: MILES INC.
Reel/Frame 007300/0052 →
Assignment of Assignor's Interest
Oct 10, 1995
From: TAMBURINI, PAUL PERRY; HUGUENEL, EDWARD DAVID; FALLON, KIMBERLY ANN
To: BAYER CORPORATION
Reel/Frame 007704/0848 →
Assignment of Assignor's Interest
Nov 24, 1995
From: KLUENDER, HAROLD CLINTON EUGENE; BRITTELLI, DAVID ROSS; COMBS, KERRY JEANNE; DIXON, BRIAN RICHARD
To: BAYER CORPORATION
Reel/Frame 007571/0765 →
Assignment of Assignor's Interest
Nov 24, 1995
From: BENZ, GUENTER HANS HEINZ HERBERT; SCHNEIDER, STEPHAN; BULLOCK, WILLIAM HARRISON
To: BAYER CORPORATION
Reel/Frame 007571/0453 →
Merger & Change of Name
Feb 20, 1996
From: MILES INC.
To: BAYER CORPORATION
Reel/Frame 007867/0785 →
Change of Name
Oct 21, 1996
From: MILES INC.
To: BAYER CORPORATION
Reel/Frame 008202/0438 →
Change of Name
Nov 4, 1996
From: MILES INC.
To: BAYER CORPORATION
Reel/Frame 008237/0975 →
Assignment of Assignor's Interest
Feb 3, 1997
From: BLOOMQUIST, BRIAN; MCCALEB, MICHAEL; CORNFIELD, LINDA; YOO-WARREN, HEEJA
To: BAYER CORPORATION
Reel/Frame 008712/0844 →
Assignment of Assignor's Interest
Feb 19, 1997
From: HU, YINGHE; BLOOMQUIST, BRIAN T.; MCCALEB, MICHAEL L.; CORNFIELD, LINDA J.
To: BAYER CORPORATION
Reel/Frame 008365/0653 →
Assignment of Assignor's Interest
Feb 28, 1997
From: CHO, MYUNG-SAM
To: GIBLIN, JAMES A.
Reel/Frame 008396/0740 →
Change of Name
Apr 7, 1997
From: MILES INC.
To: BAYER CORPORATION
Reel/Frame 008440/0591 →
Change of Name
May 6, 1997
From: MILES INC.
To: GIBLIN, JAMES A.
Reel/Frame 008491/0489 →
Assignment of Assignor's Interest
Jul 7, 1997
From: KONIG, GERHARD; GRAHAM, PAUL
To: BAYER CORPORATION
Reel/Frame 008588/0807 →
Assignment of Assignor's Interest
Jul 7, 1997
From: KONIG, GERHARD; GRAHAM, PAUL
To: BAYER CORPORATION
Reel/Frame 008588/0810 →
Assignment of Assignor's Interest
Dec 15, 1997
From: HU, YINGHE; MCCALEB, MICHAEL L.; BLOOMQUIST, BRIAN T.; FLORES-RIVEROS, JAIME
To: BAYER CORPORATION
Reel/Frame 008875/0692 →
Assignment of Assignor's Interest
Dec 15, 1997
From: KONIG, GERHARD; GRAHAM, PAUL
To: BAYER CORPORATION
Reel/Frame 008865/0637 →
Assignment of Assignor's Interest
Jul 15, 1998
From: CHO, MYUNG-SAM; TRAN, VAN-MAI
To: GIBLIN, JAMES A.
Reel/Frame 009313/0932 →
Assignment of Assignor's Interest
Jul 18, 2003
From: BAYER CORPORATION
To: BAYER PHARMACEUTICALS CORPORATION
Reel/Frame 013804/0864 →
Assignment of Assignor's Interest
Jul 18, 2003
From: BAYER CORPORATION
To: BAYER PHARMACEUTICALS CORPORATION
Reel/Frame 013804/0836 →
Confirmatory Assignment
Dec 23, 2008
From: BAYER PHARMACEUTICALS CORPORATION
To: BAYER HEALTHCARE LLC
Reel/Frame 022024/0137 →
Assignment of Assignor's Interest
Jul 27, 2009
From: BAYER PHARMACEUTICALS CORPORATION
To: BAYER HEALTHCARE LLC
Reel/Frame 023027/0804 →
Nunc Pro Tunc Assignment
Dec 4, 2009
From: BAYER PHARMACEUTICALS CORPORATION
To: BAYER HEALTHCARE AG
Reel/Frame 023605/0562 →